Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical experience with guanfacine in long-term treatment of hypertension.

× No keyword cloud information.

10 in total

1. The electrocardiographic diagnosis of left ventricular hypertrophy: correlation with quantitative angiography.

Authors: M Dolgin; V J Fisher; A Shah; B Fisher
Journal: Am J Med Sci Date: 1977 May-Jun Impact factor: 2.378

2. A new centrally action antihypertensive agent guanfacine (BS 100-141).

Authors: U C Dubach; R Huwyler; P Radielovic; M Singeisen
Journal: Arzneimittelforschung Date: 1977

3. [First experiences with BS 100-141, a new antihypertensive substance].

Authors: I Esch
Journal: Int J Clin Pharmacol Biopharm Date: 1976-09

4. Clinical experience with guanfacine in long-term treatment of hypertension. Part II: adverse reactions to guanfacine.

Authors: P Jerie
Journal: Br J Clin Pharmacol Date: 1980 Impact factor: 4.335

5. Blood pressure, heart rate, catecholamines and plasma renin activity following institution and withdrawal of guanfacine treatment in moderate hypertension.

Authors: P Manhem; B Hökfelt
Journal: Br J Clin Pharmacol Date: 1980 Impact factor: 4.335

Review 6. Pharmacokinetics and metabolism of guanfacine in man: a review.

Authors: J R Kiechel
Journal: Br J Clin Pharmacol Date: 1980 Impact factor: 4.335

7. Antihypertensive effect of N-amidino-2-(2,6-dichlorophenyl) acetamide hydrochloride. A double-blind cross-over trial versus clonidine.

Authors: W Kirch; A Distler
Journal: Int J Clin Pharmacol Biopharm Date: 1978-03

8. Studies on the clinical pharmacology of prazosin. II: The influence of indomethacin and of propranolol on the action and disposition of prazosin.

Authors: P Rubin; G Jackson; T Blaschke
Journal: Br J Clin Pharmacol Date: 1980-07 Impact factor: 4.335

9. Evaluation of long-term treatment of essential hypertension with guanfacine.

Authors: M Higuchi; A Overlack; K O Stumpe
Journal: Br J Clin Pharmacol Date: 1980 Impact factor: 4.335

10. Guanfacine: effects of long-term treatment and withdrawal.

Authors: J L Reid; C Zamboulis; C A Hamilton
Journal: Br J Clin Pharmacol Date: 1980 Impact factor: 4.335

10 in total

3 in total

1. Systems pharmacology identifies drug targets for Stargardt disease-associated retinal degeneration.

Authors: Yu Chen; Grazyna Palczewska; Debarshi Mustafi; Marcin Golczak; Zhiqian Dong; Osamu Sawada; Tadao Maeda; Akiko Maeda; Krzysztof Palczewski
Journal: J Clin Invest Date: 2013-11-15 Impact factor: 14.808

Review 2. Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.

Authors: E M Sorkin; R C Heel
Journal: Drugs Date: 1986-04 Impact factor: 9.546

3. Improvement of glucose tolerance in hypertensive diabetic patients treated with guanfacine one year.

Authors: J H Hauger-Klevene; J C Scornavacchi
Journal: Eur J Clin Pharmacol Date: 1985 Impact factor: 2.953

3 in total